Citations

Mayo Clinic

Clear

2435 citation(s) found for "Ly, Amy".

Predictors and Patterns of Nonurothelial Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma (UCAN Collaboration)
Katims, Andrew , Assel, Melissa , Margulis, Vitaly , Potretzke, Aaron M., Katims, Andrew B , Tin, Amy L. , Hensley, Patrick J. , Li, Roger , Matin, Surena F. , Pallauf, Maximilian , Potretzke, Aaron M., Clark, Roderick K. , Raman, Jay D. , Singla, Nirmish , Spiess, Philippe E. , Coleman, Jonathan

Journal of Urology | June 17, 2025 | Volume: 214 | Issue: 4 | Pages: 407-414

10.1097/ju.0000000000004646 | PMID 40526449 Get It

Meningitis as an Attack Phenotype of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Aboseif, Albert , Kim, Nee Na , Bou, Gabriela , Nathoo, Nabeela , Guo, Yong , Pique, Julie , Kerbrat, Anne, Audoin, Bertrand, Demortière, Sarah , Bourre, Bertrand , Ciron, Jonathan , Chen, John J. , Tolédano, Michel B. , Quek, Amy May Lin, Marignier, Romain , Chen, John J , Ciron, Jonathan , Nathoo, Nabeela , Aboseif, Albert , Kerbrat, Anne , Audoin, Bertrand , Bourre, Bertrand , Cacciaguerra, Laura , Toledano, Michel, Gombolay, Grace , Hacohen, Yael , Flanagan, Eoin P.

JAMA Neurology | June 16, 2025 | Volume: 82 | Issue: 8 | Pages: 871

10.1001/jamaneurol.2025.1774 | PMID 40522676 Get It

This international multicenter study seeks to determine the frequency and characteristics of meningitis in myelin oligodendrocyte glycoprotein antibody (MOGAD)–associated disease and highlight its pathology.
The Society of Pediatric Liver Transplantation ( SPLIT ): 2023 Registry Status
Banc‐Husu, Anna M. , Smith, Rachel , Kelly, Beau , Anand, Ravinder , Anderson, Sarah G. , Lobritto, Steven , Chapin, Catherine A. , Chartier, Marie‐Eve , Ekong, Udeme D. , Furuya, Katryn N. , García, Jennifer , González‐Peralta, Regino P. , Ibrahim, Samar H. , Kerkar, Nanda , Leung, Daniel H. , Ng, Vicky L. , Pai, Anita K., Pan, Debra H. , Shakhin, Victoria , Stoll, Janis , Wadera, Sheetal, Squires, James E. , (SPLIT), the Society of Pediatric Liver Transplantation, Lobritto, Steve , Elisofon, Scott A , Feldman, Amy , Gutierrez Sanchez, Luz Helena , Hildreth, Amber N , Himes, Ryan , Ibrahim, Samar H , Kerkar, Nanda , Leung, Daniel H , Mazareigos, George , Ng, Vicky L , Peters, Anna L , Shakhin, Victoria , Hsu, Evelyn , Squires, James E , Valentino, Pamela , Society of Pediatric Liver Transplantation (SPLIT) , Sanchez, Luz Helena Gutierrez , Hildreth, Amber , Jain, Ajay K. , Mazariegos, George , Valentino, Pamela L. , (SPLIT), the Society of Pediatric Liver Transplantation

Pediatric Transplantation | June 16, 2025 | Volume: 29 | Issue: 5 | Pages: No page available

10.1111/petr.70111 | PMID 40522021 Get It

ABSTRACT Background The Society of Pediatric Liver Transplantation (SPLIT) has undergone tremendous growth with > 45 sites contributing data focusing on improving outcomes in pediatric liver transplantation (LT). We report and compare outcomes from the SPLIT Registry. Methods Patients < 18 years with first‐time LT only enrolled into the SPLIT Registry between 2011 and 2023 were included. Data was stratified into eras from the last published registry update (era 1: 2011–2018, era 2: 2018–2023). Results Three thousand five hundred four participants from 47 centers were included (era 1: n = 2159; era 2: n = 1345). Age distribution differed with more children < 1 year. of age at LT in era 2 (era 1: 29% vs. era 2: 33%, p = 0.01). Indications for LT were similar, with biliary atresia (38.8%) and metabolic disease (16.0%) being most common. Exception point use was higher in era 2 (era 1: 45% vs. era 2: 56%, p < 0.001). No difference in graft type (deceased: 81% era 1 vs. 78% era 2, p = 0.78), patient survival at 90 days (era 1: 98.7% vs. era 2: 98.3%), 1 year (era 1: 97.2 vs. era 2: 96.8%), or 3 years (era 1: 95.3% vs. era 2: 95.2%) was noted. Rate of hepatic artery thrombosis was lower in era 2 (era 1: 7% vs. era 2: 5%, p = 0.02). Conclusions Trends in pediatric LT within SPLIT note similar LT indications and graft type, higher utilization of exception points, and lower HAT rates despite transplanting more children < 10 kg. This data underscores the evolution of pediatric LT toward higher survivability and overall patient outcomes.
471 | LONGITUDINAL scRNA‐seq CASE STUDY IDENTIFIES THREE STABLE AND DISTINCT B‐CELL SUBTYPES IN SERIAL SAMPLES OF A DIFFUSE B‐CELL LYMPHOMA FROM A SINGLE DOG
Treeful, Amy E. , Macchietto, Marissa , Reid, Kelly, Seelig, Davis , Demos-Davies, Kimberly , Büettner, Manuela , Pracht, Sara, Yung, C., Luethcke, R., Ditcovsky, R., Kuzmik, Alana R., Borgatti, A., Henson, Morgan , Feiock, Caitlin, Sarver, A. L., Walker, G., Winter, A., Buettner, M., Burt, L., Penza, V., Adams, R., Vallera, Daniel A. , Henson, M., Modiano, Jaime F. , Naik, S., Sarver, A. L.

Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_471 Get It

505 | EMERGING EVIDENCE OF MICROBIOTA COMPOSITION LINKED TO ADVERSE EVENTS DURING IMMUNOTHERAPY IN DOGS WITH LYMPHOMA
Treeful, Amy E. , Dietz, Michael, Reid, Kenneth , Büettner, Manuela , Chehadeh, Andrea, Pracht, Sara, Luethcke, R., Yung, C., Demos-Davies, Kimberly , Seelig, Davis , Feiock, Caitlin, Henson, Morgan , Borgatti, Antonella , Shruthi, N, Dietz, M., Reid, K., Buettner, M., Winter, A., Penza, V., Adams, R., Vallera, Daniel A. , Henson, M., Staley, Christopher , Modiano, Jaime F. , Shruthi, N.

Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_505 Get It

478 | SINGLE‐CELL RNA SEQUENCING UNCOVERS AP‐1 TRANSCRIPTIONAL UPREGULATION IN CANINE DIFFUSE LARGE B‐CELL LYMPHOMA
Sarver, Aaron L. , Treeful, Amy E. , Macchietto, Marissa , Reid, Kenneth , Seelig, Davis , Demos-Davies, Kimberly , Büettner, Manuela , Pracht, Sara, Yung, C., Luethcke, R., Borgatti, Antonella , Henson, Morgan , Feiock, Caitlin, Naik, Swati , Callaghan, C., Walker, G., Lloréns, J., Reid, K., Winter, A., Buettner, M., Burt, L., Penza, V., Adams, Ralf H. , Vallera, Daniel A. , Henson, M., Naik, S., Modiano, Jaime F.

Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_478 Get It

822 | A DOSE‐ESCALATION STUDY OF INTRAVENOUS VESICULAR STOMATITIS VIRUS TO TREAT COMPANION DOGS WITH SPONTANEOUS AGGRESSIVE LYMPHOMA (PHASE 1 OF THE ORBIT CLINICAL TRIAL)
Feiock, Caitlin, Reid, Kelly, Winter, Alexandra L. , Büettner, Manuela , Pracht, Sara, Luethcke, Kristofer Ross , Yung, Christianne, Demos-Davies, Kimberly , Seelig, Davis , Treeful, Amy E. , Henson, Morgan , Borgatti, A., Naik, Shobha, Buettner, M., Yung, C., Adams, R., Penza, V., Burt, L., Henson, M., Vallera, Daniel A. , Modiano, Jaime F. , Naik, S.

Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_822 Get It

893 | THE SAFETY AND FEASIBILITY OF INTRAVENOUS VESICULAR STOMATITIS VIRUS, AN IMMUNOGENIC ONCOLYTIC VIRUS, AS A TREATMENT FOR SPONTANEOUS AGGRESSIVE LYMPHOMA IN COMPANION DOGS
Reid, Kelly, Feiock, Caitlin, Büettner, Manuela , Pracht, Sara, Luethcke, Kristofer Ross , Seelig, Davis , Demos-Davies, Kimberly , Treeful, Amy E. , Henson, Morgan , Borgatti, A., Naik, Shobha, Winter, A., Buettner, M., Yung, C., Adams, R., Penza, V., Burt, L., Henson, M., Vallera, Daniel A. , Modiano, Jaime F. , Naik, S.

Hematological Oncology | June 15, 2025 | Volume: 43 | Issue: S3 | Pages: No page available

10.1002/hon.70096_893 Get It

Reevaluating Preoperative Type and Screen: Identifying When It Is Necessary for Elective Colorectal Surgery
Khan, Sidrah , Glasgow, Amy E. , Hajjar, Roy , Reynolds, Ian S. , Gleason, Lauren, Sanchez, Emilo, Perry, William , Mathis, Kellie L. , Glasgow, Amy, Gleason, Lauren T, Perry, William R , Reynolds, Ian S , Sanchez, Emilo, McKenna, Nicholas P.

Diseases of the Colon & Rectum | June 10, 2025 | Volume: 68 | Issue: 9 | Pages: 1093-1099

10.1097/dcr.0000000000003844 | PMID 40492559 Get It

BACKGROUND: Rising health care costs necessitate a reassessment of routine preoperative practices. Despite low transfusion rates in elective colorectal operations, many hospitals continue to perform routine preoperative type and screen testing. OBJECTIVE: To assess perioperative blood transfusion rates and determine preoperative and surgical factors associated with transfusions to determine whether the routine preoperative type and screen testing are necessary for elective abdominal colorectal surgeries, particularly in the setting of minimally invasive surgery. DESIGN: Retrospective cohort study. SETTINGS: Mayo Clinic, 2019–2023. PATIENTS: Adult patients undergoing elective abdominal colorectal operations. Exclusion criteria included emergent operations and nonabdominal procedures. INTERVENTIONS: None. MAIN OUTCOME MEASURES: The primary outcome was the incidence of intraoperative and immediate postoperative (≤72 hours) blood product transfusion. Secondary outcomes assessed associations between transfusion rates, surgical approach, and preoperative variables. RESULTS: Among 4652 patients, 2770 underwent minimally invasive surgery and 1882 underwent open procedures. Perioperative red blood cell transfusion rates were lower in minimally invasive procedures (3.0% colectomy, 4.5% proctectomy) compared to open procedures (8.7% colectomy, 21.5% proctectomy). Open proctectomy was the strongest predictor of transfusion (OR 12.05; 95% CI, 8.94–16.26; p < 0.0001) followed by open colectomy (OR 2.59; 95% CI, 2.04–3.30; p < 0.0001). Preoperative factors including ASA class IV (OR 5.21; 95% CI, 1.09–24.82; p < 0.0382) and anemia (OR 4.14; 95% CI, 3.09–5.55; p < 0.0001) were also significantly associated with red blood cell transfusion. LIMITATIONS: The retrospective nature of the study may introduce selection bias. In addition, institutional practice patterns may limit the generalizability of findings. CONCLUSIONS: Patients undergoing elective minimally invasive colorectal surgery have very low rates of perioperative blood transfusions; thus, routine preoperative type and screen testing is likely unnecessary for this patient cohort. However, patients undergoing planned open operations, likely due to procedural complexity, and those who are ASA class IV, have preoperative anemia, or have anal cancer have higher transfusion risks and may benefit from selective testing. Implementing a risk-stratified approach based on surgical technique and patient comorbidities could potentially reduce unnecessary testing and associated health care costs. See Video Abstract. RE-TIPIFICACIÓN Y EVALUACIÓN PREOPERATORIAS: CÓMO IDENTIFICAR CUÁNDO ES NECESARIA UNA CIRUGÍA COLORRECTAL ELECTIVA ANTECEDENTES: El aumento en los costos de la atención médica exigen la reevaluación de las practicas preoperatorias de rutina. A pesar de las bajas tasas de transfusión en la cirugía colorrectal electiva, muchos hospitales continúan realizando pruebas de tipo y de cribado preoperatorios de forma rutinaria. El poresente estudio evalúa las tasas de transfusiones sanguíneas perioperatorias e identifica los factores asociados con éstas transfusiones para determinar la necesidad de pruebas de tipo y de cribado preoperatorios de forma rutinaria en cirugías colorrectales abdominales electivas. OBJETIVO: Evaluar las tasas de transfusión sanguínea perioperatoria y determinar los factores preoperatorios y quirúrgicos asociados con las transfusiones, con el fin de determinar si las pruebas de tipo y de cribado preoperatorias de forma rutinaria son necesarias en cirugías colorrectales abdominales electivas, en particular en el contexto de la cirugía mínimamente invasiva. DISEÑO: Estudio de cohortes retrospectivo. ESCENARIO: Clínica Mayo, 2019-2023. PACIENTES: Pacientes adultos sometidos a cirugías colorrectales abdominales electivas. Los criterios de exclusión incluyeron operaciones de emergencia y procedimientos no abdominales. INTERVENCIONES: Ninguna. PRINCIPALES MEDIDAS DE RESULTADOS: El resultado primario fue la incidencia de transfusión de hemoderivados intraoperatoriamente y postoperatoria inmediata (≤72 horas). Los resultados secundarios evaluaron la asociación entre las tasas de transfusión, el abordaje quirúrgico y las variables preoperatorias. RESULTADOS: De 4652 pacientes, 2770 se sometieron a cirugía mínimamente invasiva y 1882 a laparotomía. Las tasas de transfusión eritrocitaria perioperatoria fueron menores en los procedimientos mínimamente invasivos (3,0 % colectomía, 4,5 % proctectomía) que en los procedimientos abiertos (8,7 % colectomía, 21,5 % proctectomía). La proctectomía abierta fue el predictor más sólido de transfusión (OR: 12,05; IC del 95 %: 8,94-16,26; p < 0,0001), seguida de la colectomía abierta (OR: 2,59; IC del 95 %: 2,04-3,30; p < 0,0001). Los factores preoperatorios, incluyendo la clase ASA IV (OR 5,21; IC del 95 %: 1,09-24,82; p < 0,0382) y la anemia (OR 4,14; IC del 95 %: 3,09-5,55; p < 0,0001), también se asociaron significativamente con la transfusión de glóbulos rojos. LIMITACIONES: La naturaleza retrospectiva del estudio puede introducir sesgo de selección. Además, los patrones de práctica institucional pueden limitar la generalización de los hallazgos. CONCLUSIONES: Los pacientes sometidos a cirugía colorrectal mínimamente invasiva electiva tienen tasas muy bajas de transfusiones sanguíneas perioperatorias, por lo que las pruebas de detección y tipo de sangre preoperatorias de rutina probablemente sean innecesarias para esta cohorte de pacientes. Sin embargo, los pacientes sometidos a cirugías abiertas planificadas, probablemente debido a la complejidad del procedimiento, y aquellos con clase ASA IV, anemia preoperatoria o cáncer anal, tienen mayor riesgo de transfusión y podrían beneficiarse de pruebas selectivas. La implementación de un enfoque estratificado por riesgo basado en la técnica quirúrgica y las comorbilidades del paciente puede reducir las pruebas innecesarias y los costos de atención médica asociados. (Traducción—Dr. Xavier Delgadillo)